Home›People›Joan LaRovere
JL

Joan LaRovere

Director at Holobiome.

Director
Updated Nov 10, 2026·Latest SEC filing Jul 22, 2026·Suggest an edit

About Joan LaRovere

Joan LaRovere is a director at Holobiome.

Joan LaRovere first appears on SEC filings in 2024.

Experience

This experience comes from Joan LaRovere's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joan LaRovere in the role, so the role may have started earlier or lasted longer.

Holobiome, Inc. Current
Director
2024 – Present · Boston, MA
Develops gut bacteria-based therapies and consumer health products for people.
LifeMD Current
Board Member (NASDAQ: LFMD)
2023 – Present
iSelect Fund Current
Healthcare Operating Partner
2021 – Present
MIT Sloan School of Management Current
Course Instructor and Mentor
2018 – Present
Martin Trust Center for MIT Entrepreneurship Current
Professional Advisor, Delta V Summer Accelerator Board Member, Start MIT and MIT Fuse EIR
2016 – Present
Harvard Medical School Current
Assistant Professor of Pediatrics
2011 – Present
Virtue Foundation Current
Co-Founder, President, and Board Member
2002 – Present
Boston Children's Hospital Current
SVP and interim Chief Medical Officer
1993 – Present
Bupa Cromwell Hospital
Consulting Physician
2000 – 2011
The Royal Brompton Hospital/ Imperial College Medical School
Chief, Pediatric Intensive Care Unit
1999 – 2011
Great Ormond Street Hospital for Children NHS Foundation Trust
Fellow, Pediatric Intensive Care/Cardiac Intensive Care
1997 – 1999

Key Colleagues at Startups

The people Joan LaRovere works with at each company, as listed on that company's latest Form D.

Holobiome, Inc. · Form D, Jul 22, 2026
Philip Strandwitz
Philip Strandwitz
Co-founder & Director; Chief Executive Officer
ML
Michael LaFleur
Executive officer

Sources

  1. SECHolobiome, Inc. Form D, filed Jul 22, 2026